The focus of new agents for treating this malignancy has been on patients with relapsed or refractory disease, which carries a poor prognosis and short life expectancy.
Multidisciplinary collaboration coupled with the use of multimodal strategies has enabled the tailoring of treatment plans based on the patient’s medical status and type of surgery.
Awareness of how to recognize and report adverse childhood events helps break generational cycles of abuse, thereby protecting the most vulnerable members of society.